To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information
I AgreeAnalysis of Sacroiliac Joint Fusion market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global sacroiliac joint fusion market size is estimated at US$ 620 Mn in 2022 and is likely to reach US$ 3,900 Mn by 2032. The market is expected to witness a CAGR of 20.2% during the forecast period from 2022 to 2032.
Report Attributes | Details |
Estimated Base Year Market Value (2021) |
US$ 540 Mn |
Anticipated Market Value in 2022 |
US$ 620 Mn |
Expected Forecast Market Value in 2032 |
US$ 3,900 Mn |
Global Growth Rate (2022-2032) |
20.2% CAGR |
Market Share of North America |
42% |
Expansion Rate of Asia Pacific |
17% CAGR |
Key Companies Profiled |
|
The growth of the market can be attributed to the rapid technical development in the healthcare sector and the growing demand for minimally invasive surgical procedures.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
The global sacroiliac joint market is likely to have secured a market value of US$ 540 Mn in 2021. The market growth can be acknowledged to the increasing adoption of technologies and new materials for offering safer joint fusions, which comprises the usage of 3D-printed titanium implants and additive manufacturing.
The sacroiliac joint fusion is likely to witness a significant rise in the coming time. The growth of the market is attributed to the increasing demand for its less invasive nature and lower costs. As per Fact. MR, the global sacroiliac joint fusion market is projected to secure a market value of US$ 3,900 Mn by 2032, while recording a CAGR of 20.2% during the timeframe of 2022 t0 2032.
Growing Demand for Minimally Invasive Surgeries to Fuel the Market
The increasing adoption of minimally invasive surgeries is anticipated to be the key factor driving the market during the forecast period. Further, the improving diagnostic capabilities for sacroiliac joint disorders and the adoption of new technologies are likely to offer better SI joint fusion systems.
In addition, the increasing geriatric population in developed countries like the US and the growing incidences of chronic diseases are anticipated to make a significant contribution in boosting the market. As per the 2019 data of the U.S Census Bureau, out of 328 million U.S population, about 75 Million were 60 years and above.
The delayed elective surgeries hampered the market growth
The outbreak of COVID-19 resulted in reduced sales and low demand for the surgeries, thereby, hampering the market. The lockdown led to the postponement of elective surgeries and delayed clinical trials, taking the market graph down. The situation increased the need for innovation in healthcare facilities.
There was a tremendous rise in virtual medical services, however, various players faced losses. For instance, SI-BONE disclosed that its operations ran at low resources owing to the reduced demand for its iFuse product. The loss incurred by the company was due to the restrictions imposed on elective procedures owing to the pandemic.
Growing Prevalence of Joint Pains is Likely to Widen Revenue Prospects
According to estimates by Fact.MR, North America is expected to account for 42% revenue in 2022 and beyond. The large share of the region can be attributed to the presence of key players, advanced healthcare infrastructure, and growing reimbursement coverage. Moreover, an increased incidence of joint pain is also widening growth prospects.
The National Center for Biotechnology Information reports that annual prevalence of low back pain among adults ranges from 15% to 45% among adults in the U.S. In response to this burden of disease, and in the hopes of improving outcomes, significant efforts have been made to better understand the various etiologies of back pain. In particular, increasing attention has recently been given to the SI joint as a pain generator, and estimates of low back pain attributable to the SI joint range by 15% to 30%.
Elevated Healthcare Spending to Ease the Burden of Joint Pains Bolstering Prospects
Asia Pacific is forecast to register an impressive growth rate across the 2022-2032 forecast period, registering a CAGR of 17%. This growth can be attributed to the presence of a large patient pool, developing healthcare facilities, and investments by key companies in this region.
High health care spending, rise in the number of minimally invasive procedures performed in the region, and high adoption of advanced technologies by the population are expected to boost sacroiliac fusion implants market growth in the Asia Pacific.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Joint Fusions for Degenerative Sacroiliitis Likely to Reign Supreme
By indication, Fact.MR expects the degenerative sacroiliitis segment to accumulate 39% of the market revenue in 2022 and beyond. High prevalence rates of degenerative sacroiliitis and the consequent improvement in improving diagnostic and treatment capabilities is driving demand.
At the same time, sacroiliac joint fusion for trauma injuries is expected to pick up considerable pace across the forecast period. The use of SI joint fusion systems in trauma indications is one the most recently approved indications by the FDA, thus contributing to the high growth rate of this segment.
Sacroiliac Joint Fusion for Surgeries to Accumulate Maximum Revenue Share
Sacroiliac joint fusion surgeries will likely account for 40% revenue in 2022. The increasing preference for minimally invasive surgeries due to the associated benefits, such as smaller incisions, reduced pain & scarring, and faster recovery times, is the major factor contributing to the high share of this segment.
As patients increasingly demand trauma-free surgeries, hospitals and other healthcare settings are emphasizing on including minimally invasive surgical alternatives, leading to reduced pain.
Prominent sacroiliac joint fusion service providers are emphasizing on a host expansion strategies, ranging from product development, new product launches, collaborations and acquisitions. Moreover, several players are also involved in offering clinical testing of their products and patent applications. Some prominent developments are as follows:
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Attribute |
Details |
Historical Data Available For |
2015-2021 |
Projected Forecast Period |
2022-2032 |
Market Analysis |
US$ Mn for Value and Units for Volume |
Key Regions Covered |
|
Key Segments Covered |
|
Key Countries Profiled |
|
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunities
Buy NowGet A Special pricing for start-ups and universities
Enquiry Before Buying- Humble, Yet Honored -
As of 2021, the sacroiliac joint fusion market was valued at US$ 540 Mn, as per Fact.MR
According to Fact.MR, demand for sacroiliac joint fusion is expected to reach US$ 620 Mn by 2022
By 2032, the sacroiliac joint fusion industry is expected to flourish at a CAGR of 20.2%
By 2032, Fact.MR foresees the sacroiliac joint fusion market to be valued at US$ 3,900 Mn
From 2015 to 2021, sacroiliac joint fusion demand surged at a CAGR of 18%
In North America, sacroiliac joint fusion surgeries will account for 42% of the global market demand in 2022
Across the Asia Pacific, demand for sacroiliac joint fusion is expected to rise at a CAGR of 17%
Degenerative sacroiliitis is expected to be the prominent indication segment, accumulating 39% market revenue in 2022
Sacroiliac joint fusion surgeries are expected to account for 40% market revenue in 2022